SAIPARENT

Sai Parenterals Limited

Pharmaceuticals

Share price

₹523

Market cap

₹2,323 Cr

1Y return

▲ 29%

A diversified pharmaceutical formulations company, Sai Parenteral's specializes in the research, development, and manufacturing of injectable and parenteral drugs for multiple therapeutic areas. Incorporated in 2001, the company maintains expertise in complex formulation technologies and operates integrated manufacturing facilities. It serves both domestic and international markets, with a focus on quality compliance and advanced pharmaceutical solutions across its product portfolio.

Investors holding Sai Parenterals Limited

Quant Mutual Fund

Mutual Fund

3.81%

Kotak Mahindra Life Insurance

Institution

2.35%

Foreign Investor

1.17%

AC

Astorne Capital

Foreign Investor

1.15%

Recent moves 4

Quant Mutual FundExited

Quant Mutual Fund, which previously held a 3.81 percent stake in Sai Parenterals Limited, is no longer listed among the company's disclosed shareholders, indicating either a complete exit or a reduction of its holding to below the 1 percent reporting requirement.

Astorne CapitalExited

Astorne Capital, which previously held a 1.15 percent stake in Sai Parenterals Limited, is no longer listed among its public shareholders, indicating either a complete sale or a reduction to below the 1 percent reporting threshold.

Kotak Mahindra Life InsuranceDecreased

Kotak Mahindra Life Insurance reduced its stake in Sai Parenterals Limited from 2.89% to 2.35% by selling 2,35,180 shares for ₹13.07 crore at ₹556.10 apiece.

Morgan StanleyNew position

Morgan Stanley acquired 514,798 shares, a 1.17% stake in Sai Parenterals Limited, valued at approximately ₹28.6 Cr. Morgan Stanley Asia (Singapore) Pte Ltd was an anchor investor in the Sai Parenterals IPO in March 2026, subscribing to shares at ₹392 apiece.

Track the whales in Sai Parenterals Limited

Get alerted the moment a top investor buys or sells.